Sixty-three patients with advanced EGFR-mutant lung cancer at 7 Canadian centers, who were being screened for the ASTRIS trial (ClinicalTrials.gov identifier: NCT02474355), participated in this ...
Tech, Inc. (OTCQB: CETI), an environmental remediation technology company, today provided a year-end update highlighting ...
Next generation sequencing (NGS) has revolutionized molecular diagnostic testing. It is important to note that, as with many molecular diagnostic tests currently in clinical use, there are very few ...
In the lab, innovation drives the development of new technology to expand research and overcome technical challenges in healthcare, pharmaceuticals and beyond. Automation is revolutionizing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback